Description
IGF-1 LR3 is a synthetic, high-purity research peptide designed for controlled laboratory studies. As a modified analog of insulin-like growth factor 1, it is primarily used to investigate how specific structural changes influence peptide stability and signaling behavior.
Product Overview and Research Utility
- Structural Modification: This analog is characterized by a defined modification—the replacement of glutamic acid with arginine at the third position.
- Study Focus: Researchers utilize this compound to examine peptide structure, modified analog behavior, and signaling patterns under repeatable conditions.
- Predictability: Its consistent, synthetic origin helps reduce variation in experimental data, making it a reliable tool for long-term, advanced laboratory projects.
Specifications
- Format: Provided in a stable format that allows for accurate measurement and controlled application.
Proper Handling and Storage
To maintain the integrity of the compound during research, scientists should adhere to standard peptide preparation and safety protocols. These practices ensure stable conditions are preserved throughout the observation and data review phases of a study.
Mandatory Notice
Research Use Only: This product is strictly for laboratory investigation and must not be used for human or animal consumption, clinical diagnostics, or any therapeutic purposes. All research must be conducted by qualified professionals in accordance with applicable regulations.
